Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 195 Myeloid 141 Sarcoma 99 Gastrointestinal 84 Lymphoid 49 CNS 23 Thoracic 19 Dermatologic 16 Genitourinary 15 Other solid neoplasm 11 Gynecologic 11 Breast 10 Tumor-Agnostic 7 Head & Neck 7 Plasma cell 4 Endocrine 2 Classical hematology 2 Other neoplasm 1 Other 1

Conditions

Mucositis 1 Leukemia 1

Interventions

Exercise 27 Metformin 24 Methods 14 Radiotherapy 13 Early Intervention, Educational 13 Educational Status 12 Counseling 12 Surveys and Questionnaires 10 Standard of Care 10 Nutrition Assessment 9 Resistance Training 8 Diet Therapy 8 Cisplatin 8 naloxegol 7 Tirzepatide 7 Diet 7 alvimopan 6 Psychiatric Rehabilitation 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 Radiation 5 Low-Level Light Therapy 5 Liraglutide 5 Injections 5 Exenatide 5 Dexamethasone 5 Cryotherapy 5 semaglutide 4 angiotensin I (1-7) 4 Vitamin D 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Imatinib Mesylate × Other × Clear all

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡